Nomenclature
CAS number: 54504-70-0
2-(4-Chlorophenoxy)-2-methylpropanoic acid 2-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-7
H-purin-7-yl)ethyl ester; 2-(
p-chlorophenoxy)-2-methylpropionic acid ester
with 7-(2-hydroxyethyl)theophylline; 1-(theophyllin-7-yl)ethyl 2-(
p-chlorophenoxy)isobutyrate; etofylline clofibrate; ML-1024; Duolip (Merckle).
C
19H
21ClN
4O
5; mol wt 420.85.
C 54.22%, H 5.03%, Cl 8.42%, N 13.31%, O 19.01%.
Description and references
Deriv of clofibric acid, q.v., with antilipemic, antithrombotic, and platelet-aggregation
inhibitory activity: Prepn: G. Metz, M. Specker, DE 2308826; eidem, US 3984413 (1974, 1976 both to Merckle); eidem, Arzneim.-Forsch. 25, 1686 (1975).
Hypolipemic activity: G. Metz et al., ibid. 27, 1173 (1977). Series
of articles on chemistry, biopharmaceutic evaluation, pharmacology,
toxicology, clinical studies: ibid. 30, 2013-2074 (1980).
Properties
Colorless crystals from ethanol, mp 133-135°. Practically insol in
water at pH 2-7.4 and in cold alcohols. Sol in acetone, chloroform,
hot alcohols. LD50 in mice, rats, dogs
(g/kg): 11.7, 17.0, >10.0 orally (Metz et al.).Therapeutic Category
Antilipemic.
Keywords
Antilipemic; Fibrates